Hybrid: Director of European Rare-Disease Market Access

Il y a 2 jours

Paris, Nouvelle-Aquitaine, France Regeneron Pharmaceuticals, Inc Temps plein 100 000 € - 167 000 € Contrat

Regeneron Pharmaceuticals, Inc. seeks a Director, Regional Market Access, Rare Diseases, Europe to drive pricing, reimbursement, and patient access strategies in a hybrid setup. The role collaborates with global, regional, and local teams to shape value propositions and access plans across Europe.

The candidate will lead access strategies, monitor payer trends and HTA submissions, and engage with payers and policymakers to advance patient access while aligning with global objectives.